SUCCESS in osteoarthritis (OA) trial: celecoxib significantly reduces the risk of upper gastrointestinal (UGI) hospitalizations compared to diclofenac and naproxen in 13,274 randomized patients with OA [Abstract] - Goldstein, JL (European League Against Rheumatism)
Prague, Czech Republic, June 13–16, 2001.